 Home > Biochemistry News > Biotechnology News > NK cell therapy for non-small cell lung cancer enhances Keytruda's anticancer activity

NK cell therapy for non-small cell lung cancer enhances Keytruda's anticancer activity

 Last Update: 2022-02-26
 Source: Internet
 Author: User

Tags

kaiser test results

convene meeting

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, NKGen Biotech announced that the autologous natural killer (NK) cell therapy SNK01, in combination with the PD-1 inhibitor pembrolizumab (Keytruda), is used in the treatment of non-small cell lung cancer (NSCLC) 1 / Phase 2a clinical trial with positive data

The trial enrolled 18 patients with advanced non-small cell lung cancer who had failed previous first-line platinum-based therapy

▲NKGen's innovative NK cell immunotherapy uses high-purity NK cells extracted from the patient's blood, expanded and activated, and then returned to the patient

The trial data showed that patients in the SNK01 combination treatment group achieved a statistically significant better median PFS (6.

Dr.

References:

[1] NKGen Biotech Announces Positive SNK01 Clinical Trial Results Presented at the Society for Immunotherapy of Cancer (SITC) 2021 Annual Meeting.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.